YTHDF2 and cardiac hypertrophy: Moreover, Xu et al. (86) showed that administration of AAV9 particles carrying YTHDF2 plasmids through tail vein injection for 3 weeks alleviated cardiac hypertrophy in mice after TAC surgery, indicated by a reduced heart size, decreased hypertrophic cardiomyocytes, and less fibrosis.